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intracranial Vasculopathy 
in a Patient with Systemic 
Sclerosis: Atherosclerotic or 
Moyamoya-Like Disease?
To the Editor,
Systemic sclerosis (SSc) is a chronic multi-systemic 
disorder of unknown etiology characterized by immune 
activation, tissue fibrosis due to excessive synthesis and 
deposition of extracellular matrix, and vasculopathy 
due to vascular endothelial cell activation and injury. 
Peripheral vascular involvement manifesting as Rayn-
aud’s phenomenon (RP) is one of the common clinical 
features of SSc [1]. However, neurological complications 
and cerebral vasculopathies representative of macro-
vascular complications occur uncommonly [2]. Here we 
report a patient with cerebral vasculopathy associated 
with limited SSc. Cerebral angiography showed an oc-
clusive lesion of the middle cerebral arteries (MCAs) 
and abnormal collateral vessels similar to those ob-
served in patients with moyamoya disease. 
A 48-year-old woman presented with RP, xerostomia, 
arthritic pain, general swelling, and thickening of the 
skin below the forearm level. She was diagnosed with 
limited scleroderma and had been prescribed oral D-
penicillamine and low-dose methylprednisolone. Labo-
ratory examination revealed positive reactions for se-
rum antinuclear (1:640, speckled pattern) and anti-Scl 
70 antibodies, and negative results for anti-neutrophil 
cytoplasmic, anti-centromere, and anti-SSA and -SSB 
antibodies. One year later, she complained of a head-
ache and severe dizziness that lasted for 2 months, and 
was admitted to a general ward via the rheumatology 
outpatient department. Her lipid profile was within nor-
mal limits. She was normotensive and other vital signs 
were within the normal range. She had no other past 
medical history except SSc, and in terms of familial 
history, her mother had diabetes mellitus. She did not 
complain of otolaryngologic symptoms. There were no 
other focal neurologic findings such as blurred vision, 
ataxia, or pathologic nystagmus. She underwent brain 
magnetic resonance imaging and magnetic resonance 
angiography (MRA); these revealed an occlusive lesion 
in the left MCA, and collateral vascular supply from the 
left external cerebral artery, which are similar to cere-
bral artery-mimicking moyamoya vessels (Fig. 1). For 
further evaluation of this abnormal vasculature, digital 
subtract angiography (DSA) of the internal carotid ar-
tery (ICA), external carotid artery and vertebral artery   
was performed. The DSA result was similar to that of 
the MRA, and several collateral circulations from both 
posterior cerebral arteries to both MCAs were observed 
(Suzuki grade II [3]) (Fig. 2). Blood chemistry tests (total 
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Figure 1. Isolated occlusion of the left middle cerebral artery 
and segmental stenosis (less than 50%) of the right distal M1.240    The Korean journal of Internal Medicine Vol. 27, No. 2, june 2012
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cholesterol and low-density lipoprotein) and cardiovas-
cular evaluation (trans-thoracic echocardiogram and 
3D cardiac computed tomography) revealed no specific 
findings or risk factors for atherosclerotic disease. A 
single-photon emission computed tomography study 
showed no definitive abnormality in cerebral blood flow 
either at baseline or after acetazolamide injection (Fig. 
3). After symptomatic treatment, she was discharged 
and has since been without neurological deficit.
Moyamoya disease is a macrovascular disease that in-
volves the ICA and development of collateral vessels. In 
a typical case, vascular imaging reveals the appearance 
of a “puff of smoke” due to obliteration of the cerebral 
microvasculature [3,4]. Although the exact pathophysi-
ologic mechanism has not yet been elucidated, vessel 
occlusion in moyamoya disease results from a combina-
tion of hyperplasia of smooth muscle cells and luminal 
thrombosis. The media are often attenuated with ir-
regular elastic lamina. Caspase-dependent apoptosis 
has been proposed as a contributory mechanism in the 
associated degradation of the arterial wall [4].
In contrast, limited scleroderma usually involves 
small vessels. Comorbid vasculopathy in SSc involves 
all layers of the vessel wall and is characterized by fi-
brotic intimal hyperplasia. As a result, vessels lose their 
elasticity and become narrower. In time, the arterial 
intima may thicken and occlusion of the small arteries 
can facilitate the formation of in situ thrombosis. These 
vasculopathies can occur in the form of pulmonary 
arterial hypertension, scleroderma renal crisis, digital 
ulceration, or infarct. 
A unique finding in our patient was the combination 
of limited scleroderma and cerebral angiographic find-
ings showing abnormal vasculature. Although microvas-
cular disease is a hallmark of SSc, there is an ongoing 
debate regarding the presence and extent of macrovas-
Figure 2. Digital substract angiography showing (A) moderate stenosis of the right proximal middle cerebral artery (MCA), and (B) left 
proximal MCA occlusion. (C) Collateral blood was supplied by both posterior cerebral artery, with the left side being dominant.
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cular diseases and the presence of accelerated athero-
sclerosis in limited SSc. It is usually limited to the ulnar 
or cerebral arteries, but its causal relationship with vas-
cular endothelial damage has not yet been elucidated. A 
previous study suggested that there is a progressive and 
highly significant reduction in the elastic properties of 
the carotid artery of SSc patients compared to non-SSc 
subjects [5]. Arterial elastic properties are good mark-
ers of early atherosclerosis, and augmented carotid in-
tima-media thickness may be more prevalent in sclero-
derma patients and related to antibodies against human 
heat shock protein (HSP)-60 and mycobacterial HSP-
65 [6]. However, these moyamoya-like changes, which 
represent MCA occlusion and collateral circulation for 
the stenotic cerebral arteries, occur not only in patients 
with moyamoya disease but also in those with other 
disorders, such as atherosclerosis, Down’s syndrome, 
neurofibromatosis type 1, and systemic lupus erythema-
tosus. Terajima et al. [7] reported a typical case of moy-
amoya disease with transient ischemic attack showing 
bilateral obliterative cerebral vasculopathy. However, 
our case showed non-specific neurologic symptoms and 
unilateral occlusion of cerebral vessels. In this case, be-
cause the patient had no risk factors for atherosclerosis 
and showed no signs of ischemic stroke, we considered 
moyamoya-like vascular changes a possible cause of 
MCA occlusion. Because up to two-thirds of moyamoya 
patients may exhibit symptomatic progression over a 
5-year period, the clinical symptoms and signs of isch-
emic cerebral occlusion in this SSc case will be followed 
carefully.
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Figure 3. Radionuclide resting cerebral blood flow (rCBF) study with 600 MBq 
99mTc-ECD baseline (A), and 800 MBq 
99mTc-ECD 
after injection of 1,000 mg acetazolamide (B) by single-photon emission computed tomography (SPECT) showed no definite blood flow 
abnormality in the cerebral hemispheres.
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